Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality differences in coronary patients with breast cancer treated with trimetazidine dihydrochloride: potential therapeutic implications.

Cardio-oncology (London, England)·2025
Same author

Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride.

Communications medicine·2025
Same author

Treatment with trimetazidine dihydrochloride and lung cancer survival: Implications on metabolic re-programming.

Lung cancer (Amsterdam, Netherlands)·2024
Same author

Beliefs on the causes of birth defects as perceived by mothers of children with birth defects in a tertiary care hospital in the Philippines.

Journal of community genetics·2022
Same author

Prenatal phenotype of Kabuki syndrome: A case series and literature review.

Prenatal diagnosis·2021
Same author

Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong.

American journal of medical genetics. Part A·2020

Related Experiment Video

Updated: Jun 18, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Issues on universal screening for galactosemia.

Carmencita David Padilla1, Stephen T S Lam

  • 1Department of Pediatrics, College of Medicine, University of the Philippines Manila. carmencita.padilla@gmail.com

Annals of the Academy of Medicine, Singapore
|November 12, 2009
PubMed
Summary
This summary is machine-generated.

Galactosemia, a metabolic disorder, can be detected early through newborn screening. However, ongoing debates question the benefits of universal screening due to complications despite early treatment.

More Related Videos

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
14:43

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish

Published on: July 18, 2020

Related Experiment Videos

Last Updated: Jun 18, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
14:43

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish

Published on: July 18, 2020

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Galactosemia is an inherited metabolic disorder affecting galactose breakdown.
  • It involves deficiencies in three key enzymes: GALK, GALT, and GALE.
  • Newborn screening aims for early diagnosis and treatment of galactosemia.

Purpose of the Study:

  • To present arguments for and against universal newborn screening for galactosemia.
  • To address the ongoing debate surrounding the efficacy of early detection and treatment.

Main Methods:

  • Literature review of studies on galactosemia and newborn screening.
  • Analysis of reported outcomes and complications in treated patients.
  • Synthesis of evidence supporting and opposing universal screening protocols.

Main Results:

  • Newborn screening enables early identification of galactosemia.
  • Despite early treatment, some patients experience complications.
  • Evidence supporting universal screening is challenged by these reports.

Conclusions:

  • The benefits of universal newborn screening for galactosemia remain a subject of debate.
  • Further research is needed to optimize screening protocols and treatment strategies.
  • Balancing early detection with potential long-term outcomes is critical.